Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Vakiener Victoria, Director. Insider active across 1 company, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 12 disclosures have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €1m. History available since 10 January 2023. The latest transaction was disclosed on 19 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Vakiener Victoria serves as a Director at ARROWHEAD PHARMACEUTICALS, INC. In this role, she contributes to the governance and strategic direction of the company. Her experience in the biopharmaceutical sector allows her to provide valuable insights on growth and innovation opportunities. Victoria plays a key role in overseeing operations and evaluating company performance.